Sofie A M Gernaat
Overview
Explore the profile of Sofie A M Gernaat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gernaat S, Simard J, Altman M, Svenungsson E, Arkema E
BMJ Open
. 2024 Dec;
14(12):e090555.
PMID: 39719298
Objectives: The objectives of the study are to investigate infection risk in offspring born to women with systemic lupus erythematosus (SLE) compared with offspring born to women without SLE and...
2.
Johnsson A, Kiani N, Gernaat S, Wilking U, Shabo I, Hedayati E
Cancer Med
. 2023 Mar;
12(9):10840-10850.
PMID: 36880198
Background: Planning for return to work (RTW) is relevant among sub-groups of metastatic breast cancer (mBC) survivors. RTW and protective factors for RTW in patients with mBC were determined. Methods:...
3.
Altena R, Gernaat S, Wilking U, Kiani N, Johnsson A, Hedayati E
Eur J Cancer Care (Engl)
. 2022 May;
31(5):e13626.
PMID: 35621269
Objective: The objective of this study is to determine the prevalence and predictors of sickness absence (SA) and disability pension (DP) in women with metastatic breast cancer (mBC). Methods: Data...
4.
Gernaat S, Simard J, Wikstrom A, Svenungsson E, Arkema E
J Rheumatol
. 2021 Dec;
49(5):465-469.
PMID: 34853085
Objective: To investigate the risk of gestational diabetes mellitus (GDM) associated with systemic lupus erythematosus (SLE) by comparing pregnancies in women with SLE to general population controls. Methods: We identified...
5.
Gal R, van Velzen S, Hooning M, Emaus M, van der Leij F, Gregorowitsch M, et al.
JAMA Oncol
. 2021 May;
7(7):1024-1032.
PMID: 33956083
Importance: Cardiovascular disease (CVD) is common in patients treated for breast cancer, especially in patients treated with systemic treatment and radiotherapy and in those with preexisting CVD risk factors. Coronary...
6.
Gernaat S, Johnsson A, Altena R, Wilking U, Hedayati E
Eur J Cancer Care (Engl)
. 2020 Nov;
30(1):e13353.
PMID: 33151558
Objective: We aimed to determine the longitudinal prevalence and the predictors of sickness absence (SA) and disability pension (DP) in breast cancer (BC) women who eventually developed relapse. Methods: A...
7.
Emaus M, Isgum I, van Velzen S, van den Bongard H, Gernaat S, Lessmann N, et al.
BMJ Open
. 2019 Jul;
9(7):e028752.
PMID: 31352417
Introduction: Cardiovascular disease (CVD) is an important cause of death in breast cancer survivors. Some breast cancer treatments including anthracyclines, trastuzumab and radiotherapy can increase the risk of CVD, especially...
8.
Hedayati E, Papakonstantinou A, Gernaat S, Altena R, Brand J, Alfredsson J, et al.
Eur Heart J Qual Care Clin Outcomes
. 2019 Jul;
6(2):147-155.
PMID: 31328233
Aims: Heart failure (HF) patients diagnosed with breast cancer (BC) may have a higher risk of death, and different HF presentation and treatment than patients without BC. Methods And Results:...
9.
Buddeke J, Gernaat S, Bots M, van den Bongard D, Grobbee D, Vaartjes I, et al.
BMJ Open
. 2019 Jun;
9(5):e022664.
PMID: 31152022
Objectives: To investigate trends in cardiovascular disease (CVD) risk following breast cancer using national registry data. Methods: A nationwide cohort study was conducted, comprising 163 881 women with in situ...
10.
Gernaat S, van Velzen S, Koh V, Emaus M, Isgum I, Lessmann N, et al.
Radiother Oncol
. 2018 Apr;
127(3):487-492.
PMID: 29703498
Purpose: This study automatically quantified calcifications in coronary arteries (CAC) and thoracic aorta (TAC) on breast planning computed tomography (CT) scans and assessed its reproducibility compared to manual scoring. Material...